Tonix Pharmaceuticals Appoints EVP to Lead AI and Partnership Efforts

Tonix appointed George Lederman, Ph.D., as EVP of Strategy and Transformation, effective October 30, 2026. He will lead AI initiatives and business development, including evaluating partnerships and licensing opportunities for clinical programs.